Role of central and peripheral ghrelin in the mechanism of gastric mucosal defence.
Ghrelin, identified in the gastric mucosa, has been involved in the control of food intake and growth hormone (GH) release, but whether this hormone influences the gastric secretion and gastric mucosal integrity has been little elucidated. We compared the effects of intraperitoneal (i.p.) and intracerebroventricular (i.c.v.) administration of ghrelin on gastric secretion and gastric lesions induced in rats by 75% ethanol or 3.5 h of water immersion and restraint stress (WRS) with or without suppression of nitric oxide (NO)-synthase or functional ablation of afferent sensory nerves by capsaicin. The number and the area of gastric lesions was measured by planimetry, the GBF was assessed by the H2-gas clearance method and blood was withdrawn for the determination of the plasma ghrelin and gastrin levels. In addition, the gastric mucosal expression of mRNA for CGRP, the most potent neuropeptide released from the sensory afferent nerves, was analyzed in rats exposed to WRS with or without ghrelin pre-treatment. Ghrelin (5-80 microg/kg i.p. or 0.6-5 microg/kg i.c.v.) increased gastric acid secretion and attenuated gastric lesions induced by ethanol and WRS. This protective effect was accompanied by a significant rise in the gastric mucosal blood flow (GBF), luminal NO concentration and plasma ghrelin and gastrin levels. Ghrelin-induced protection was abolished by vagotomy and significantly attenuated by L-NNA and deactivation of afferent nerves with neurotoxic dose of capsaicin. The signal for CGRP mRNA was significantly increased in gastric mucosa exposed to WRS as compared to that in the intact gastric mucosa and this was further enhanced in animals treated with ghrelin. We conclude that central and peripheral ghrelin exerts a potent protective action on the stomach of rats exposed to ethanol or WRS, and these effects depend upon vagal activity and hyperemia mediated by the NOS-NO system and CGRP released from sensory afferent nerves.
Brzozowski
Tomasz
T
Department of Physiology, Jagiellonian University Medical College, 16 Grzegorzcka Street, 31-531 Cracow, Poland. mpbrzozo@cyf-kr.edu.pl
Konturek
Peter C
PC
Drozdowicz
Danuta
D
Konturek
Stanislaw J
SJ
Pawlik
Michal
M
Sliwowski
Zbigniew
Z
Pawlik
Wieslaw W
WW
Hahn
Eckhart G
EG
D000208:Acute Disease; D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000235:genetics / Q000378:metabolism; D002211:Capsaicin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D000431:Ethanol / Q000008:administration & dosage; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism; D005755:Gastrins / Q000097:blood; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D015870:Gene Expression / Q000187:drug effects; D054439:Ghrelin; D007101:Immersion / Q000009:adverse effects; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D019335:Nitroarginine / Q000494:pharmacology; D036361:Peptide Hormones / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D012333:RNA, Messenger / Q000737:chemistry / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D013312:Stress, Physiological / Q000209:etiology / Q000503:physiopathology; D014628:Vagotomy / Q000379:methods; D014867:Water
D004791:Enzyme Inhibitors; D005755:Gastrins; D054439:Ghrelin; D036361:Peptide Hormones; D012333:RNA, Messenger; D014867:Water; D019335:Nitroarginine; D009569:Nitric Oxide; D000431:Ethanol; D019001:Nitric Oxide Synthase; D015740:Calcitonin Gene-Related Peptide; D002211:Capsaicin